Skip to content

Time to Peak Effect of Propofol in Children

Time to Peak Effect of Propofol in Children

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03426462
Acronym
TPEPC
Enrollment
48
Registered
2018-02-08
Start date
2018-04-23
Completion date
2018-12-04
Last updated
2019-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child, Propofol

Keywords

Pharmacodynamic, Permutation Entropy, EEG

Brief summary

In order to determine the speed of onset of the anaesthetic propofol in children, investigators will compare the two age groups 1-6 years vs 8-13 years. The primary outcome measure is the time to peak effect of a bolus of proposal, which is measured by analysing the electroencephalogram by using the permutation entropy. Further pharmacodynamic modelling will enable investigators to quantify the difference with age in the hypnotic effect of propofol.

Interventions

DRUGPropofol

Induction of anesthesia and two further deepening episodes will be performed whilst recording the electroencephalogram.

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

The analysis of the electroencephalogram will be blinded to the age of the participant.

Intervention model description

Age groups 1-6 years will be compared with 8-13 years whilst undergoing propofol anesthesia to detect whether there is indeed a difference in the speed of onset of the hypnotic effect of the drug.

Eligibility

Sex/Gender
ALL
Age
1 Years to 13 Years
Healthy volunteers
Yes

Inclusion criteria

* The study population will be healthy children in the ranges of 1-6 and 8-13 years of age having surgery with American Society of Anaesthesia (ASA) grades I-II (ie. no prior functional limitation due to comorbidities) that fulfil the following points: * parental written consent obtained at least a day prior to begin of the subject's study episode; and * the child is appropriate for induction and maintenance of anaesthesia with propofol.

Exclusion criteria

* Any significant subject co-morbidity (ASA III or IV); * Withdrawal of consent/assent at any point in the study; * Failure to cannulate a peripheral vein prior to induction after two attempts; * Any other reason making IV induction with propofol impossible; * Allergy to propofol (or its emulsion carrier), Eutectic Mixture of Local Anesthetics (EMLA) cream or Nitrous Oxide (N2O); * previous enrolment in the study; * Any anaesthetic problem that would take precedence over completion of the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Time to peak effect of a propofol bolusup to 20 minutes from baseline until peak effect following second bolus administrationThis is the time from the start of the propofol bolus administration to the maximal suppression of the electroencephalogram; per subject two boli will be administered

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026